CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The new online Learning Center with new content can still be found under the “Training” folder on ...